Evercore ISI Group Maintains Outperform on Roku, Lowers Price Target to $140
Evercore ISI Group analyst Shweta Khajuria maintains Roku (NASDAQ:ROKU) with a Outperform and lowers the price target from $185 to $140.
Evercore ISI Group Maintains In-Line on Netflix, Lowers Price Target to $245
Evercore ISI Group analyst Mark Mahaney maintains Netflix (NASDAQ:NFLX) with a In-Line and lowers the price target from $300 to $245.
Evercore ISI Group Maintains Outperform on Match Group, Lowers Price Target to $95
Evercore ISI Group analyst Mark Mahaney maintains Match Group (NASDAQ:MTCH) with a Outperform and lowers the price target from $115 to $95.
Evercore ISI Group Maintains Outperform on Meta Platforms, Lowers Price Target to $280
Evercore ISI Group analyst Mark Mahaney maintains Meta Platforms (NASDAQ:META) with a Outperform and lowers the price target from $325 to $280.
Evercore ISI Group Maintains Outperform on Lyft, Lowers Price Target to $42
Evercore ISI Group analyst Mark Mahaney maintains Lyft (NASDAQ:LYFT) with a Outperform and lowers the price target from $45 to $42.
Evercore ISI Group Maintains Outperform on Grab Hldgs, Lowers Price Target to $5
Evercore ISI Group analyst Mark Mahaney maintains Grab Hldgs (NASDAQ:GRAB) with a Outperform and lowers the price target from $6 to $5.
Evercore ISI Group Maintains In-Line on eBay, Lowers Price Target to $50
Evercore ISI Group analyst Mark Mahaney maintains eBay (NASDAQ:EBAY) with a In-Line and lowers the price target from $59 to $50.
Evercore ISI Group Maintains Outperform on Booking Holdings, Lowers Price Target to $2600
Evercore ISI Group analyst Mark Mahaney maintains Booking Holdings (NASDAQ:BKNG) with a Outperform and lowers the price target from $3000 to $2600.
Lake Street Maintains Buy on DiaMedica Therapeutics, Lowers Price Target to $8
Lake Street analyst Thomas Flaten maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and lowers the price target from $14 to $8.
Craig-Hallum Maintains Buy on Aspen Aerogels, Lowers Price Target to $32
Craig-Hallum analyst Eric Stine maintains Aspen Aerogels (NYSE:ASPN) with a Buy and lowers the price target from $50 to $32.